BindingDB logo
myBDB logout

null

SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H]3[C@H]2O\C(=N/CCCN(C)C)N3C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC

InChI Key: InChIKey=WBDMEXWZCXEWGM-ISHVPQBTSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50393730   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cytochrome P450 3A4


(Homo sapiens (Human))
BDBM50393730
PNG
(CHEMBL2159131)
Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H]3[C@H]2O\C(=N/CCCN(C)C)N3C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC |r|
Show InChI InChI=1S/C43H77N3O13/c1-16-30-43(10,51)35(48)25(4)32(47)23(2)21-42(9,53-15)37(59-39-34-29(20-24(3)54-39)46(13)40(58-34)44-18-17-19-45(11)12)26(5)33(27(6)38(50)56-30)57-31-22-41(8,52-14)36(49)28(7)55-31/h23-31,33-37,39,48-49,51H,16-22H2,1-15H3/b44-40-/t23-,24-,25+,26+,27-,28+,29+,30-,31+,33+,34-,35-,36+,37-,39+,41-,42-,43-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 8.00E+3n/an/an/an/an/an/a



GlaxoSmithKline Research Centre Zagreb

Curated by ChEMBL


Assay Description
Inhibition of human recombinant CYP3A4 using 7-BQ as substrate preincubated for 5 to 10 mins before substrate addition


J Med Chem 55: 6111-23 (2012)


Article DOI: 10.1021/jm300356u
BindingDB Entry DOI: 10.7270/Q29G5NX3
More data for this
Ligand-Target Pair
Cytochrome P450 3A4


(Homo sapiens (Human))
BDBM50393730
PNG
(CHEMBL2159131)
Show SMILES CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H]3[C@H]2O\C(=N/CCCN(C)C)N3C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC |r|
Show InChI InChI=1S/C43H77N3O13/c1-16-30-43(10,51)35(48)25(4)32(47)23(2)21-42(9,53-15)37(59-39-34-29(20-24(3)54-39)46(13)40(58-34)44-18-17-19-45(11)12)26(5)33(27(6)38(50)56-30)57-31-22-41(8,52-14)36(49)28(7)55-31/h23-31,33-37,39,48-49,51H,16-22H2,1-15H3/b44-40-/t23-,24-,25+,26+,27-,28+,29+,30-,31+,33+,34-,35-,36+,37-,39+,41-,42-,43-/m1/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 700n/an/an/an/an/an/a



GlaxoSmithKline Research Centre Zagreb

Curated by ChEMBL


Assay Description
Inhibition of human recombinant CYP3A4 using DEF as substrate preincubated for 5 to 10 mins before substrate addition


J Med Chem 55: 6111-23 (2012)


Article DOI: 10.1021/jm300356u
BindingDB Entry DOI: 10.7270/Q29G5NX3
More data for this
Ligand-Target Pair